PATENT CLAIM ANALYSIS

Application Number: 15926716
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "192100"]

Abstract:
Provided herein are methods, compositions, and kits for preventing, inhibiting, reducing the severity of, or treating a disease or condition. A pharmaceutical composition provided herein can comprise a nucleic acid sequence encoding an antigen fused to an immune cell product, e.g., MIP-3α, and an adjuvant. The antigen can be from a bacteria, virus, fungus, parasite, or cancer. The antigen can be an Alzheimer's disease antigen.

Claim (Index 108):
The method of  claim 105 , wherein the nucleic acid is a deoxyribonucleic acid (DNA).

Metadata:
- Claim Count in Document: 284.0
- Percentile: 90.0
- Lexical Diversity: 1.60784
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13206471', '13823581', '12928044', '13373224', '15512820']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7660501849573275
- 35 USC 102 Novelty (BERT): 0.5599513740174323
- Combined Prediction Score: 0.7454403038633379
- Mean Citation Score: 322.40604399999995
- Max Citation Score: 493.97092
- Similarity Product: 301.8336336167097

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test